Skip to main content
. 2022 May 4;105:103709. doi: 10.1016/j.drugpo.2022.103709

Table 1.

Sample description by 60-day adherence to novel opioid alternatives.

Overall
Adherence at 60 days
p-value
Yes No
N = 286 N = 221 N = 65
Demographics

Age (mean (SD)) 39.02 (10.63) 39.93 (10.82) 35.94 (9.39) 0.008
Sex (%) F 104 (36.4) 77 (34.8) 27 (41.5) 0.401
M 182 (63.6) 144 (65.2) 38 (58.5)
Client (%) New client 84 (29.4) 59 (26.7) 25 (38.5) 0.02
Outreach only 9 (3.1) 5 (2.3) 4 (6.2)
Existing client 156 (54.5) 131 (59.3) 25 (38.5)
Client limited Interaction 37 (12.9) 26 (11.8) 11 (16.9)
Comorbidities

HCV Diagnosis (%) No 129 (45.1) 96 (43.4) 33 (50.8) <0.001
Yes 120 (42.0) 104 (47.1) 16 (24.6) Yes
Unknown 37 (12.9) 21 (9.5) 16 (24.6)
HIV Diagnosis (%) No 225 (78.7) 179 (81.0) 46 (70.8) 0.065
Yes 13 (4.5) 11 (5.0) 2 (3.1)
Unknown 48 (16.8) 31 (14.0) 17 (26.2)
Asthma, COPD, or Chronic Bronchitis Diagnosis (%) No 200 (69.9) 158 (71.5) 42 (64.6) 0.004
Yes 49 (17.1) 42 (19.0) 7 (10.8)
Unknown 37 (12.9) 21 (9.5) 16 (24.6)
Head injury or Stroke Diagnosis (%) No 192 (67.1) 148 (67.0) 44 (67.7) <0.001
Yes 54 (18.9) 50 (22.6) 4 (6.2)
Unknown 40 (14.0) 23 (10.4) 17 (26.2)
Chronic Pain Diagnosis (%) No 142 (49.7) 107 (48.4) 35 (53.8) 0.005
Yes 106 (37.1) 91 (41.2) 15 (23.1)
Unknown 38 (13.3) 23 (10.4) 15 (23.1)
Dental Pain Diagnosis (%) No 199 (69.6) 160 (72.4) 39 (60.0) 0.077
Yes 38 (13.3) 29 (13.1) 9 (13.8)
Unknown 49 (17.1) 32 (14.5) 17 (26.2)
Skin or Tissue Damage (%) No 130 (45.5) 101 (45.7) 29 (44.6) 0.003
Yes 126 (44.1) 104 (47.1) 22 (33.8)
Unknown 30 (10.5) 16 (7.2) 14 (21.5)
Injection Drug Use (Ever; %) No 12 (4.2) 12 (5.4) 0 (0.0) 0.067
Yes 214 (74.8) 167 (75.6) 47 (72.3)
Unknown 60 (21.0) 42 (19.0) 18 (27.7)
Mental Disorder (%) No 21 (7.3) 18 (8.1) 3 (4.6) 0.03
Yes 198 (69.2) 159 (71.9) 39 (60.0)
Unknown 67 (23.4) 44 (19.9) 23 (35.4)
ADHD Diagnosis (%) No 163 (57.0) 134 (60.6) 29 (44.6) 0.021
Yes 39 (13.6) 31 (14.0) 8 (12.3)
Unknown 84 (29.4) 56 (25.3) 28 (43.1)
Anxiety Diagnosis (%) No 113 (39.5) 94 (42.5) 19 (29.2) 0.018
Yes 93 (32.5) 74 (33.5) 19 (29.2)
Unknown 80 (28.0) 53 (24.0) 27 (41.5)
Depression Diagnosis (%) No 112 (39.2) 91 (41.2) 21 (32.3) 0.027
Yes 89 (31.1) 73 (33.0) 16 (24.6)
Unknown 85 (29.7) 57 (25.8) 28 (43.1)
Bipolar Disorder Diagnosis (%) No 191 (66.8) 156 (70.6) 35 (53.8) 0.022
Yes 11 (3.8) 9 (4.1) 2 (3.1)
Unknown 84 (29.4) 56 (25.3) 28 (43.1)
PTSD Diagnosis (%) No 128 (44.8) 106 (48.0) 22 (33.8) 0.011
Yes 69 (24.1) 56 (25.3) 13 (20.0)
Unknown 89 (31.1) 59 (26.7) 30 (46.2)
Complex or Conduct Disorder Diagnosis (%) No 135 (47.2) 106 (48.0) 29 (44.6) 0.001
Yes 74 (25.9) 66 (29.9) 8 (12.3)
Unknown 77 (26.9) 49 (22.2) 28 (43.1)
Received Mental Health Medications (%) No 191 (66.8) 139 (62.9) 52 (80.0) 0.001
Yes 77 (26.9) 71 (32.1) 6 (9.2)
Unknown 18 (6.3) 11 (5.0) 7 (10.8)
Substance Use History

Recent Overdose in Past Six Months (%) No 121 (42.3) 97 (43.9) 24 (36.9) 0.533
Yes 71 (24.8) 52 (23.5) 19 (29.2)
Unknown 94 (32.9) 72 (32.6) 22 (33.8)
Recent Crystal Meth Use (%) No 86 (30.1) 68 (30.8) 18 (27.7) 0.754
Yes 188 (65.7) 143 (64.7) 45 (69.2)
Unknown 12 (4.2) 10 (4.5) 2 (3.1)
Recent Injection Drug Use (%) No 78 (27.3) 62 (28.1) 16 (24.6) 0.173
Yes 181 (63.3) 142 (64.3) 39 (60.0)
Unknown 27 (9.4) 17 (7.7) 10 (15.4)
Recent Smoking Drug Use (%) No 33 (11.5) 27 (12.2) 6 (9.2) 0.278
Yes 205 (71.7) 161 (72.9) 44 (67.7)
Unknown 48 (16.8) 33 (14.9) 15 (23.1)
Housing Conditions

Was Homeless No 46 (16.1) 37 (16.7) 9 (13.8) 0.732
Yes 239 (83.6) 183 (82.8) 56 (86.2)
Unknown 1 (0.3) 1 (0.5) 0 (0.0)
Initiated Prescription While in Homeless Camp (%) No 199 (69.6) 154 (69.7) 45 (69.2) 0.986
Yes 73 (25.5) 56 (25.3) 17 (26.2)
Unknown 14 (4.9) 11 (5.0) 3 (4.6)
Participant Admitted to Temporary Sheltering Site during Follow-up (%) No 104 (36.4) 75 (33.9) 29 (44.6) 0.247
Yes 179 (62.6) 144 (65.2) 35 (53.8)
Unknown 3 (1.0) 2 (0.9) 1 (1.5)